Year 2019
April 2019


Teijin Pharma Limited manufactures and markets pharmaceutical and home healthcare products in three dedicated areas of expertise, namely bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company offers pharmaceutical drugs, Sonic Accelerated Fracture Healing System devices, oxygen concentrators, and Continuous Positive Airway Pressure devices.

Teijin Pharma was established in 1978 and now operates as a subsidiary of Teijin Limited. Its headquarters are located in Tokyo, Japan; with office locations in the United Kingdom, Spain, South Korea, China and North America. Teijin Pharma markets and distributes its products through a strong network of distributors in Japan and internationally.

We currently distribute the following product from Teijin Pharma.

Bon-One Tablet (Prescription-Only Medicine)

Active Ingredient:   

  • Alfacalcidol (1-α-hydroxyvitamin D3)


  • Improvement of various symptoms (hypocalcemia, tetany, bone pain, bone lesions, etc.) due to abnormal vitamin D metabolism in the following conditions:
    • Chronic renal failure
    • Hypoparathyroidism
    • Vitamin D-resistant rickets and osteomalacia
    • Osteoporosis